Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cappellini

Showing results (691-700 of 863) with videos related to

Pageof 87
Sort By:
Haematologica|September 18, 2012
Mosaic segmental uniparental isodisomy and progressive clonal selection: a common mechanism of late onset β-thalassemia majorCornelis L Harteveld, Chiara Refaldi, Antonino Giambona, et al.
Annals of Hematology|June 19, 2013
Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA studyAli T Taher, John B Porter, Vip Viprakasit, et al.
Journal of Hepatology|July 21, 2023
Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trialDavid J Kuter, Herbert L Bonkovsky, Susana Monroy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2017
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)Alessandro Poli, Stefano Ratti, Carlo Finelli, et al.
Blood Cells, Molecules & Diseases|February 9, 2016
Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS studyAli T Taher, M Domenica Cappellini, Yesim Aydinok, et al.
Orphanet Journal of Rare Diseases|September 24, 2020
Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?Maja Di Rocco, Alessio Di Fonzo, Antonio Barbato, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 21, 2023
The diagnostic performances of the Atellica® 1500 automated urinalysis system for ruling out bacterial urinary tract infectionPietro Iezzi, Fabrizio Cappellini, Jari Intra, et al.
Journal of Clinical Medicine|February 26, 2025
Multidisciplinary Therapeutic Approaches to Pancreatic Cancer According to the Resectability StatusAurelio Mauro, Carlotta Faverio, Leonardo Brizzi, et al.
American Journal of Hematology|April 5, 2013
Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patientsAli T Taher, John B Porter, Vip Viprakasit, et al.
Journal of Personalized Medicine|March 29, 2023
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?Sabrina Chiloiro, Antonella Giampietro, Antonio Bianchi, et al.
Pageof 87

Showing results (691-700 of 863) with videos related to

Sort By:
Pageof 87
Haematologica|September 18, 2012
Mosaic segmental uniparental isodisomy and progressive clonal selection: a common mechanism of late onset β-thalassemia majorCornelis L Harteveld, Chiara Refaldi, Antonino Giambona, et al.
Annals of Hematology|June 19, 2013
Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA studyAli T Taher, John B Porter, Vip Viprakasit, et al.
Journal of Hepatology|July 21, 2023
Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trialDavid J Kuter, Herbert L Bonkovsky, Susana Monroy, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 4, 2017
Nuclear translocation of PKC-α is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)Alessandro Poli, Stefano Ratti, Carlo Finelli, et al.
Blood Cells, Molecules & Diseases|February 9, 2016
Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS studyAli T Taher, M Domenica Cappellini, Yesim Aydinok, et al.
Orphanet Journal of Rare Diseases|September 24, 2020
Parkinson's disease in Gaucher disease patients: what's changing in the counseling and management of patients and their relatives?Maja Di Rocco, Alessio Di Fonzo, Antonio Barbato, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 21, 2023
The diagnostic performances of the Atellica® 1500 automated urinalysis system for ruling out bacterial urinary tract infectionPietro Iezzi, Fabrizio Cappellini, Jari Intra, et al.
Journal of Clinical Medicine|February 26, 2025
Multidisciplinary Therapeutic Approaches to Pancreatic Cancer According to the Resectability StatusAurelio Mauro, Carlotta Faverio, Leonardo Brizzi, et al.
American Journal of Hematology|April 5, 2013
Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patientsAli T Taher, John B Porter, Vip Viprakasit, et al.
Journal of Personalized Medicine|March 29, 2023
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?Sabrina Chiloiro, Antonella Giampietro, Antonio Bianchi, et al.
Pageof 87